Navigation Links
InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
Date:6/27/2011

Commercial Director at ZAO Implanta. “We are aware that there is an acute need for an improved solution for heart attack patients and our country is making giant steps to improve the treatment options.  By 2013, our aim is to achieve primary PCI rates of more than 600 per one million inhabitants per year.  We are confident that cardiologists throughout the Russian Federation will want to learn more about the advantages MGuard offers, for heart attack patients, and as InspireMD continues to clinically validate its technology, we believe interest will grow and the MGuard stent will take a significant share of the Russian market.”

About ZAO Implanta

ZAO Implanta was established in 1998.  Their main activities are delivering innovative medical technologies to the Russian Federation Market, equipping health facilities with modern equipment and training of medical personnel. IMPLANTA offers medical products in the areas of arrhythmology, neurosurgery, cardiac surgery and vascular and has a network of seven regional offices in the Russian Federation: Vladivostok, Nizhny Novgorod, St. Petersburg, Samara, Yekaterinburg, Novosibirsk and Krasnodar.

About MGuard Coronary

MGuard is a combination of a coronary stent merged with an embolic protection specifically designed for Acute MI patients. The embolic protection is comprised of an ultra-thin polymer mesh sleeve that wraps the stent. The MGuard coronary seeks to provide permanent embolic protection, without affecting deliverability. MGuard is CE Mark approved. Mesh-based protection is now recommended for use in the recent Guidelines of the Task force of Myocardial Revascularization of the European Society of Cardiology (ESC).

About InspireMD Inc.

InspireMD is an innovative medical device company focusing on the development a
'/>"/>

SOURCE InspireMD
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InspireMD Announces Year-to-Date 2011 Progress
2. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
3. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
4. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
5. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
6. InspireMD Boosts MGuard Production Capacity
7. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
8. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
9. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
10. United Spinal Association Broadens Its Reach with Users First: Giving Voice to All Wheelchair Users
11. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today it has completed enrollment of ... Review Committee (DRC) earlier this year, into the ... a first-in-class innate defense regulator (IDR) and is ...
(Date:8/31/2015)... Aug. 31, 2015  QT Vascular Ltd., together with its ... with its subsidiaries, the "Group"), a global company ... advanced therapeutic solutions for the minimally invasive treatment ... of the below-the-knee ("BTK") cohort of patients in ... presented on August 15, 2015 at the 5th ...
(Date:8/30/2015)... y LONDRES, August 30, 2015 ... holística de l cuidado al paciente ... trayecto   Royal Philips  ... europeo de IntelliSpace Cardiovascular , un sistema web ... herramientas para acceder, analizar y compartir imágenes cardiovasculares e ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
... Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery and life sciences ... Austria AG for the co-development and manufacture of ... The agreement combines Sony DADC,s premier Blu-ray Disc™ ...
... Nov. 3, 2010 Cyberonics, Inc. (Nasdaq: CYBX ) ... second quarter ended October 29, 2010 of its fiscal year ending ... ET.  The company will conduct a conference call to discuss those ... Fiscal Year 2011 Second Quarter Results Conference Call InstructionsTo ...
Cached Medicine Technology:Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results 2
(Date:9/1/2015)... ... September 01, 2015 , ... ... has established the MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It ... rapidly-growing alliance is dedicated to the provision of quality addiction treatment and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Elizabeth Callahan, MD, founder and ... first in the area to offer RADIESSE® filler treatment for volume loss in the ... of tendons and veins in the hands, delivering smooth, natural-looking results that can last ...
(Date:9/1/2015)... IL (PRWEB) , ... September 01, 2015 , ... ... and Zeel™, has recently sponsored an educational workshop for physician assistants (PAs) practicing ... Injections of Traumeel™ and Zeel™” was held by Dr. Erick Salado, an orthopedic ...
(Date:9/1/2015)... ... September 01, 2015 , ... Curly Hair ... hair salons. This highly anticipated partnership between Curly Hair Solutions™ and Trade Secrets ... Founder Jonathan Torch and the Curly Hair Solutions™ team could not be more ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... released their latest predictive use case focused on helping hospital perform under the ... this program, hospital payments are adjusted based on performance across four domains related ...
Breaking Medicine News(10 mins):Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2
... , HOFFMAN ESTATES, Ill., July 16 ... America,s top medical institutions in the annual America,s Best Hospitals list published ... magazine. St. Alexius Medical Center was ranked among the top 50 hospitals ... , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090716/CG47487 ) ...
... NATICK, Mass., July 16 Boston Scientific Corporation (NYSE: ... from the U.S. Food and Drug Administration (FDA) to market ... drug-eluting stent (DES) designed for long lesions. At 38 ... option that can potentially reduce the number of stents used ...
... , PEKIN, Ill., July 16 ... of prescription foot and ankle orthoses and accompanying high technology ... award, which is given annually by the national Department of ... employment opportunities and support to veterans. , ...
... WALTHAM, Mass., July 16 According to Millennium ... intelligence, the fat reduction device market will experience the highest ... MRG,s European Markets for Body Contouring Devices 2009 ... fueled by physician adoption of newer modalities like transdermal ultrasound ...
... , , FRANKLIN, Mass., ... a company focused on innovative cardiac and vascular medical device-based ... Cardiac Angiography in Renally Impaired Patients (CARE) Study determined that ... from pulmonary edema to death, and that patients with CIN ...
... , , , BEIJING, July ... access to fast and efficient radiotherapy treatments with the introduction of ... ) at the Beijing Cancer Hospital. BCH is the first ... more advanced care to a greater number of patients. , ...
Cached Medicine News:Health News:St. Alexius Medical Center Named to America's Best Hospitals Rankings 2Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 2Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 3Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 4Health News:PAL Health Technologies Wins State-Level Prestigious 'Employer of the Year' Award 2Health News:Fat Reduction Market in Europe to Soar Despite Economic Downturn 2Health News:PLC Medical Systems Announces Publication of Care Study Update 2Health News:PLC Medical Systems Announces Publication of Care Study Update 3Health News:Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 2Health News:Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 3
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This instrument can be used as a spoon forceps in gynecologic surgery....
This is a single-action instrument that features a spring handle....
Medicine Products: